Mr Mathias Winkler Consultant urologist
- Patient age group
- Adults
- Consultant registered on
- 01/02/1995
- Primary medical qualifications
- State Exam Med 1992 Medizinisch Akademie Magdeburg
- Foreign languages
- Gender
- Male
- Services
- Hospitals
Contact
- Phone
- 020 3313 0046
Background
Matt has been a consultant urological surgeon at Chelsea & Westminster NHS Foundation Trust and Charing Cross Hospital since 2007. With extensive training in Germany, New York, and England, he specializes in minimally invasive pelvic surgery. His intercalated degree in biochemistry and an MD in prostate cancer laid the foundation for his dedication to advancing the diagnosis and treatment of prostate cancer. Further expertise in statistics and machine learning has enabled him to drive impactful clinical research in his field.
Currently, Matt practices part-time at the West Middlesex Hospital, where he chairs the cancer multidisciplinary team (MDT). He previously chaired the specialist prostate cancer MDT at Imperial College Healthcare NHS Trust for over a decade, leading a multidisciplinary team to manage numerous prostate cancer cases annually. During his tenure, he spearheaded innovations in service delivery, introducing advancements such as:
- Focal therapy
- Prostate MRI-based diagnostics
- Targeted and robotic transperitoneal prostate biopsy
- MRI-guided MDT discussions
- Day-case laparoscopic prostatectomy
- In-bore MRI-guided HIFU
- Retzius-sparing robotic surgery
- Prehabilitation seminars
As a high-volume robotic prostate cancer surgeon utilizing the Da Vinci robot, Matt has established a consistent record of high-quality outcomes.
His clinical research focuses on improving prostate cancer diagnosis and treatment, with particular interest in novel imaging biomarkers, focal therapies, and surgical innovations to reduce treatment burdens for patients. He holds a position as Visiting Reader at the Institute of Global Health Innovation, Imperial College London, where his research furthers advancements in the field.
Beyond clinical work, Matt is deeply committed to men’s health advocacy. As a board trustee of The Mulberry Centre, a holistic cancer charity, he works to raise awareness of prostate cancer testing and increase engagement among men, including those from underrepresented cultural minorities.
Matt also plays an active role in shaping the future of surgical education, mentoring and training the next generation of patient-centered, responsive professionals.
Expertise
Urology oncology, prostate cancer, robotic surgery, general urology.
Research & publications
Publications:
Alshaker, H., Krell, J., Frampton, A.E., Waxman, J., Blyuss, O., Zaikin, A., Winkler, M., et al. (2014) Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Res, Oct 25, 16(5), 426
Dickinson, L., Ahmed, H.U., Kirkham, A.P., Allen, C., Freeman, A., Barber, J., Hindley, R.G., Leslie, T., Ogden, C., Persad, R., Winkler, M.H., Emberton, M. (2013) INDEX Study Group. A multi-centre prospective development study evaluating focal therapy using high-intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials, Sep, 36(1), 68-80
Dudderidge, T.J., Doyle, P., Mayer, E.K., Taylor, J., Agrawal, S., Stolzenburg, J.U., Winkler, M.H. (2012) Evolution of care pathway for laparoscopic radical prostatectomy. J Endourol, Jun, 26(6), 660-5
Faure Walker, N.A., Nir, D., Simmons, L., Agrawal, S., Chung, C., Leminski, A., Rashid, T., Shamsuddin, A., Winkler, M. (2015) Using imaging biomarkers to improve the planning of radical prostatectomies. Urol Oncol, Jan, 33(1), 17
Karavitakis, M., Winkler, M., Abel, P., Livni, N., Beckley, I., Ahmed, H.U. (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis, Mar, 14(1), 46-52